Trial Profile
Clinical Trials Insight: 700044862
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 May 2009
Price :
$35
*
At a glance
- Drugs EP 42675 (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- Sponsors Endotis Pharma
- 26 May 2009 New trial record.